Clinical Trial: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ONO-6414 Administered Orally in Healthy Adult Participants and Patients With Active Ulcerative Colitis

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749768) titled 'A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ONO-6414 Administered Orally in Healthy Adult Participants and Patients With Active Ulcerative Colitis' on July 31.

Brief Summary: A study to investigate the safety, tolerability, and pharmacokinetics (PK) of ONO-6414 orally in healthy adult participants and in patients with active ulcerative colitis (UC).

Study Start Date: Sept. 30

Study Type: INTERVENTIONAL

Condition: Ulcerative Colitis (UC)

Intervention: DRUG: ONO-6414

Administered orally

DRUG: Placebo

Administered orally

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Ono Pharmaceutical Co., Ltd....